CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia

Published:2019-01 Issue:1 Volume:51 Page:1-15
ISSN:1226-3613
Container-title:Experimental & Molecular Medicine
language:en
Short-container-title:Exp Mol Med

Author:

Jang Woori,Park Joonhong,Kwon Ahlm,Choi Hayoung,Kim Jiyeon,Lee Gun Dong,Han Eunhee,Jekarl Dong Wook,Chae Hyojin,Han Kyungja,Yoon Jae-Ho,Lee Seok,Chung Nack-Gyun,Cho Bin,Kim Myungshin^ORCID,Kim Yonggoo

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://www.nature.com/articles/s12276-018-0195-x.pdf

Reference42 articles.

1. Mullighan, C. G. Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia. Haematologica 94, 1338–1340 (2009).

2. Pui, C. H. & Evans, W. E. Treatment of acute lymphoblastic leukemia. N. Engl. J. Med. 354, 166–178 (2006).

3. Van Vlierberghe, P. & Ferrando, A. The molecular basis of T cell acute lymphoblastic leukemia. J. Clin. Invest. 122, 3398–3406 (2012).

4. Karrman, K. & Johansson, B. Pediatric T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 56, 89–116 (2017).

5. Neumann, M. et al. Mutational spectrum of adult T-ALL. Oncotarget 6, 2754–2766 (2015).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of DNMT3a mutation in acute myeloid leukemia and its prognostic implication;Egyptian Journal of Medical Human Genetics;2024-09-02

2. Allogeneic haematopoietic stem cell transplantation might overcome the poor prognosis of adolescents and adult patients with T-lineage acute lymphoblastic leukaemia and CDKN2 deletion;Bone Marrow Transplantation;2024-05-20

3. Chromosome 9;Cancer Genes;2023-07-09

4. Copy Number Alterations in CDKN2A/2B and MTAP Genes Are Associated With Low MEF2C Expression in T-cell Acute Lymphoblastic Leukemia;Cureus;2022-12-03

5. EGCG Prevents the Transcriptional Reprogramming of an Inflammatory and Immune-Suppressive Molecular Signature in Macrophage-like Differentiated Human HL60 Promyelocytic Leukemia Cells;Cancers;2022-10-16